| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.7M | — | +20.8% |
| SG&A Expense | $4.0M | — | -44.7% |
| Operating Income | -$8.8M | — | +21.7% |
| Interest Expense | $20K | — | -88.9% |
| Pre-tax Income | -$6.7M | — | +47.9% |
| Income Tax | $0 | — | — |
| Net Income | -$6.7M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | -11.6% | -42.0% |
| Current Assets | $40.0M | -11.1% | -40.2% |
| Total Assets | $40.6M | -11.5% | -40.6% |
| Current Liabilities | $6.2M | +43.6% | -17.6% |
| Total Liabilities | $6.6M | +31.2% | -20.4% |
| Stockholders' Equity |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | +48.2% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$300K | — | +6.3% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$4.3M | — | +48.4% |
| +47.9% |
| EPS (Basic) | -$0.01 | — | +50.0% |
| EPS (Diluted) | -$0.01 | — | +50.0% |
| $34.1M |
| -16.8% |
| -43.3% |